Find your next paid study

National Human Genome Research Institute (NHGRI)NCT05657405

~$10 – $675

Actual pay is set by the research site.

Combined Cardiac Rehabilitation and Inspiratory Muscle Training in Heart Failure

The purpose of this study is to understand if breathing muscle training combined with cardiac rehabilitation influences the blood flow and blood pressure respo…

HealthyHeart Failure

Advanced Solid TumorsNon-Small Cell Lung CancerTriple Negative Breast Cancer (TNBC)+4 more

Actual pay is set by the research site.

Mayo ClinicNCT04984473

Phase 1

A Phase 1/2, Multicenter, Multi-cohort, Open-label Study of an Autologous Tumor-infiltrating Lymphocytes (TIL) Regimen With IOV-5001 in Participants With Previously Treated Advanced Solid Tumors

A Phase 1/2, multicenter, multi-cohort, open-label study of an autologous tumor-infiltrating lymphocytes (TIL) regimen with IOV-5001 in participants with previ…

Iovance Biotherapeutics, Inc.NCT07743723

~$150 – $4,200

Actual pay is set by the research site.

Phase 1

A 12-Month, Open-Label Study Evaluating Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Siplizumab as Induction Therapy in Patients With Autoimmune Liver Diseases Undergoing Liver Transplantation (SET-SAIL)

There is a significant unmet need for safe and effective therapeutic approaches to prevent immune-mediated graft injury and its complications in liver transpla…

Autoimmune Liver DiseaseLiver Transplant DisorderAutoimmune Hepatitis+3 more

Elizabeth C. VernaNCT06455280

~$150 – $4,500

Actual pay is set by the research site.

ParentingMental Health Wellness 1Substance Use+1 more

A Multiregional RCT of Parenting in 2 Worlds for Urban American Indian Families

This research study will test the effectiveness of a culturally grounded parenting intervention called Parenting in 2 Worlds (P2W). This intervention is design…

Arizona State UniversityNCT06324318

~$75 – $2,000

Actual pay is set by the research site.

MitoQ (Mitoquinol Mesylate) to Ameliorate Vascular Function in Preeclampsia: a Novel Approach

Preeclampsia is a leading cause of maternal and neonatal morbidity and mortality. There is a lack of effective therapeutics for prevention or treatment. Our pr…

PreeclampsiaPregnancy

Medical College of WisconsinNCT07229261

Actual pay is set by the research site.

Medical OncologyIntegrative OncologyMedical Nutrition Therapy

A Pilot, Feasibility Study of Intermittent Caloric Restriction Plus Plant-based Protein Diet in Cancer Patients Receiving Chemotherapy

Caloric restriction may alter the response to chemotherapy induced stress response and enhance its antitumor effect. This study intends to use an intermitted c…

State University of New York at BuffaloNCT05359848

Actual pay is set by the research site.

Phase 1

Human Models of Selective Insulin Resistance: Alpelisib, Part I

The goal of this clinical trial is to understand how the blood sugar-lowering hormone insulin works in healthy adults versus those who are at risk for type 2 d…

Insulin ResistancePrediabetic StateOverweight and Obesity+1 more

Columbia UniversityNCT06354088

~$500 – $7,500

Actual pay is set by the research site.

HER2-positive Breast CancerAdvanced Breast Cancer

Prolonged Overnight Fasting and/or Exercise on Fatigue and Other Patient Reported Outcomes in Women With Hormone Receptor Positive Advanced Breast Cancer (FastER)

The purpose of this study is to test whether four different supportive care programs can reduce fatigue in women with advanced or metastatic breast cancer who …

University of MiamiNCT06123988

Actual pay is set by the research site.

Extranodal Marginal Zone Lymphoma

Phase II Trial of Mosunetuzumab in Patients With Newly Diagnosed Extranodal Marginal Zone Lymphoma (EMZL) (ML44933)

The purpose of this study is to test a new medication called Mosunetuzumab to see if it can help people with Extranodal Marginal Zone Lymphoma (EMZL). This stu…

Izidore Lossos, MDNCT06569680

~$75 – $3,000

Actual pay is set by the research site.

Intrahepatic CholangiocarcinomaFGFR2 Gene RearrangementFGFR2 Gene Mutation

A Phase II Study of Pemigatinib Plus Durvalumab (MEDI4736) in Previously Treated Advanced Intrahepatic Cholangiocarcinoma Patients With FGFR-2 Fusion or Rearrangement

This is a single arm phase II study of pemigatinib and durvalumab combination in patients with FGFR-2 fusion or rearrangement positive intrahepatic cholangioca…

~$75 – $3,000

Actual pay is set by the research site.

Mehmet AkceNCT06728410

CD19 PositiveMixed Phenotype Acute Leukemia (MPAL)

A Multicenter Phase II Study of Subcutaneous Blinatumomab for Treatment of Adult Patients With CD19-Positive Mixed Phenotype Acute Leukemia (MPAL)

This is a multicenter, non-randomized, open-label, phase II study evaluating blinatumomab administered subcutaneously in adult subjects with CD19+ MPAL. This t…